Lung epithelial-C/EBPβ contributes to LPS-induced inflammation and its suppression by formoterol

Biochemical and Biophysical Research Communications

Volumn 423, Issue 1, 2012, Pages 134-139

  Roos, Abraham B ^a   Barton, Jenny L ^b   Miller Larsson, Anna ^c   Dahlberg, Benita ^a   Berg, Tove ^a   Didon, Lukas ^a   Nord, Magnus ^a,d  

^a KAROLINSKA INSTITUTE   (Sweden)

^b UNIVERSITY OF LEEDS   (United Kingdom)

^c ASTRAZENECA R AND D   (Sweden)

^d ASTRAZENECA R AND D   (Sweden)

Author keywords

2 Agonist; Airway epithelium; Glucocorticoid; Inflammatory mediators; Neutrophil

Indexed keywords

BUDESONIDE; CCAAT ENHANCER BINDING PROTEIN BETA; CXCL1 CHEMOKINE; CXCL2 CHEMOKINE; CYCLIC AMP; FORMOTEROL; FORSKOLIN; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INTERLEUKIN 1BETA; INTERLEUKIN 6; LIPOPOLYSACCHARIDE; TUMOR NECROSIS FACTOR ALPHA;

ANIMAL EXPERIMENT; ARTICLE; CONTROLLED STUDY; GENE EXPRESSION; IN VITRO STUDY; LUNG ALVEOLUS EPITHELIUM; LUNG FLUID; LUNG LAVAGE; MOUSE; NEUTROPHIL; NEUTROPHILIA; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; TRANSACTIVATION;

ADRENERGIC BETA-2 RECEPTOR AGONISTS; ANIMALS; BRONCHOALVEOLAR LAVAGE; CCAAT-ENHANCER-BINDING PROTEIN-BETA; CHEMOKINE CXCL1; ETHANOLAMINES; GLUCOCORTICOIDS; HUMANS; LIPOPOLYSACCHARIDES; LUNG; MICE; MICE, MUTANT STRAINS; NEUTROPHILS; PNEUMONIA; RESPIRATORY MUCOSA;

MUS;

EID: 84862648520     PISSN: 0006291X     EISSN: 10902104     Source Type: Journal    
DOI: 10.1016/j.bbrc.2012.05.096     Document Type: Article

References (40)

1. Rabe K.F., Hurd S.S., Anzueto A., Barnes P.J., Buist S.A., Calverley P.M.A., Fukuchi Y., Jenkins C.R., Rodriguez-Roisin R., van Weel C., Zielinski J. G.I.f.C.O.L. Disease, Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease: GOLD executive summary. Am. J. Respir. Crit. Care Med. 2007, 176:532-555.
2. Hoogerwerf J.J., de Vos A.F., Bresser P., van der Zee J.S., Pater J.M., de Boer A., Tanck M., Lundell D.L., Her-Jenh C., Draing C., von Aulock S., van der Poll T. Lung inflammation induced by lipoteichoic acid or lipopolysaccharide in humans. Am. J. Respir. Crit. Care Med. 2008, 178:34-41.
3. Bozic C.R., Gerard N.P., von Uexkull-Guldenband C., Kolakowski L.F., Conklyn M.J., Breslow R., Showell H.J., Gerard C. The murine interleukin 8 type B receptor homologue and its ligands: expression and biological characterization. J. Biol. Chem. 1994, 269:29355-29358.
4. Tateda K., Moore T.A., Newstead M.W., Tsai W.C., Zeng X., Deng J.C., Chen G., Reddy R., Yamaguchi K., Standiford T.J. Chemokine-dependent neutrophil recruitment in a murine model of Legionella pneumonia: potential role of neutrophils as immunoregulatory cells. Infect. Immun. 2001, 69:2017-2024.
5. Barnes P.J. The cytokine network in chronic obstructive pulmonary disease. Am. J. Respir. Cell. Mol. Biol. 2009, 41:631-638.
6. Barton J.L., Berg T., Didon L., Nord M. The pattern recognition receptor Nod1 activates CCAAT/enhancer binding protein {beta} signalling in lung epithelial cells. Eur. Respir. J. 2007, 30:214-222.
7. Cassel T.N., Nord M. C/EBP transcription factors in the lung epithelium. Am. J. Physiol. Lung. Cell. Mol. Physiol. 2003, 285:L773-781.
8. Didon L., Qvarfordt I., Andersson O., Nord M., Riise G.C. Decreased CCAAT/enhancer binding protein transcription factor activity in chronic bronchitis and COPD. Chest 2005, 127:1341-1346.
9. Roth M., Johnson P.R.A., Rudiger J.J., King G.G., Ge Q., Burgess J.K., Anderson G., Tamm M., Black J.L. Interaction between glucocorticoids and [beta]2 agonists on bronchial airway smooth muscle cells through synchronised cellular signalling. Lancet 2002, 360:1293.
10. Yin F., Wang Y.-Y., Du J.-H., Li C., Lu Z.-Z., Han C., Zhang Y.-Y. Noncanonical cAMP pathway and p38 MAPK mediate [beta]2-adrenergic receptor-induced IL-6 production in neonatal mouse cardiac fibroblasts. J. Mol. Cell. Cardiol. 2006, 40:384.
11. Berg T., Cassel T.N., Schwarze P.E., Nord M. Glucocorticoids regulate the CCSP and CYP2B1 promoters via C/EBPbeta and delta in lung cells. Biochem. Biophys. Res. Commun. 2002, 293:907-912.
12. Berg T., Didon L., Barton J., Andersson O., Nord M. Glucocorticoids increase C/EBPbeta activity in the lung epithelium via phosphorylation. Biochem. Biophys. Res. Commun. 2005, 334:638-645.
13. Zhang N., Truong-Tran Q.A., Tancowny B., Harris K.E., Schleimer R.P. Glucocorticoids enhance or spare innate immunity: effects in airway epithelium are mediated by CCAAT/enhancer binding proteins. J. Immunol. 2007, 179:578-589.
14. Ramji D.P., Foka P. CCAAT/enhancer-binding proteins: structure, function and regulation. Biochem. J. 2002, 365:561-575.
15. Didon L., Barton J.L., Roos A.B., Gaschler G.J., Bauer C.M.T., Berg T., Stampfli M.R., Nord M. Lung epithelial CCAAT/enhancer-binding protein-{beta} is necessary for the integrity of inflammatory responses to cigarette smoke. Am. J. Respir. Crit. Care Med. 2011, 184:233-242.
16. Wiley R.E., Cwiartka M., Alvarez D., Mackenzie D.C., Johnson J.R., Goncharova S., Lundblad L., Jordana M. Transient corticosteroid treatment permanently amplifies the Th2 response in a murine model of asthma. J. Immunol. 2004, 172:4995-5005.
17. Roos A.B., Berg T., Barton J.L., Didon L., Nord M. Airway epithelial cell differentiation during lung organogenesis requires C/EBPalpha and C/EBPbeta. Dev. Dyn. 2012, 241:911-923.
18. Gronning L.M., Dahle M.K., Tasken K.A., Enerback S., Hedin L., Tasken K., Knutsen H.K. Isoform-specific regulation of the CCAAT/enhancer-binding protein family of transcription factors by 3',5'-cyclic adenosine monophosphate in Sertoli cells. Endocrinology 1999, 140:835-843.
19. Rodrigues A., Queiróz D.B.C., Honda L., Silva E.J.R., Hall S.H., Avellar M.C.W. Activation of toll-like receptor 4 (TLR4) by in vivo and in vitro exposure of rat epididymis to lipopolysaccharide from Escherichia Coli. Biol. Reprod. 2008, 79:1135-1147.
20. Giembycz M.A., Newton R. Beyond the dogma: novel beta2-adrenoceptor signalling in the airways. Eur. Respir. J. 2006, 27:1286-1306.
21. Edwards M.R., Haas J., Panettieri R.A., Johnson M., Johnston S.L. Corticosteroids and beta2 agonists differentially regulate rhinovirus-induced interleukin-6 via distinct Cis-acting elements. J. Biol. Chem. 2007, 282:15366-15375.
22. Holden N.S., Rider C.F., Bell M.J., Velayudhan J., King E.M., Kaur M., Salmon M., Giembycz M.A., Newton R. Enhancement of inflammatory mediator release by β2-adrenoceptor agonists in airway epithelial cells is reversed by glucocorticoid action. Brit. J. Pharmacol. 2010, 160:410-420.
23. Giebelen I.A., Leendertse M., Dessing M.C., Meijers J.C., Levi M., Draing C., von Aulock S., van der Poll T. Endogenous beta-adrenergic receptors inhibit lipopolysaccharide-induced pulmonary cytokine release and coagulation. Am. J. Respir. Cell. Mol. Biol. 2008, 39:373-379.
24. Strandberg K., Palmberg L., Larsson K. Effect of formoterol and salmeterol on IL-6 and IL-8 release in airway epithelial cells. Respir. Med. 2007, 101:1132-1139.
25. Wilson S.J., Wallin A., Della-Cioppa G., Sandstrom T., Holgate S.T. Effects of budesonide and formoterol on NF-kappaB, adhesion molecules, and cytokines in asthma. Am. J. Respir. Crit. Care Med. 2001, 164:1047-1052.
26. Poli V. The role of C/EBP isoforms in the control of inflammatory and native immunity functions. J. Biol. Chem. 1998, 273:29279-29282.
27. Lee Y., Williams S., Baer M., Sterneck E., Gonzalez F., Johnson P. The ability of C/EBP beta but not C/EBP alpha to synergize with an Sp1 protein is specified by the leucine zipper and activation domain. Mol. Cell. Biol. 1997, 17:2038-2047.
28. Boruk M., Savory J.G.A., Hache R.J.G. AF-2-dependent potentiation of CCAAT enhancer binding protein {beta}-mediated transcriptional activation by glucocorticoid receptor. Mol. Endocrinol. 1998, 12:1749-1763.
29. Shuman J.D., Cheong J., Coligan J.E. ATF-2 C/EBPalpha can form a heterodimeric DNA binding complex in vitro: functional implications for transcriptional regulation. J. Biol. Chem. 1997, 272:12793-12800.
30. Kim J-W., Tang Q.-Q., Li X., Lane M.D. Effect of phosphorylation and S-S bond-induced dimerization on DNA binding and transcriptional activation by C/EBPbeta. Proc. Natl. Acad. Sci. U. S. A. 2007, 104:1800-1804.
31. El-Asmar B., Giner X.C., Tremblay J.J. Transcriptional cooperation between NF-kappaB p50 and CCAAT/enhancer binding protein beta regulates Nur77 transcription in Leydig cells. J. Mol. Endocrinol. 2009, 42:131-138.
32. Nirodi C., Hart J., Dhawan P., Moon N.-S., Nepveu A., Richmond A. The role of CDP in the negative regulation of CXCL1 gene expression. J. Biol. Chem. 2001, 276:26122-26131.
33. Korkmaz B., Horwitz M.S., Jenne D.E., Gauthier F. Neutrophil, elastase proteinase 3, and cathepsin G as therapeutic targets in human diseases. Pharmacol. Rev. 2010, 62:726-759.
34. Bafadhel M., McKenna S., Terry S., Mistry V., Reid C., Haldar P., McCormick M., Haldar K., Kebadze T., Duvoix A., Lindblad K., Patel H., Rugman P., Dodson P., Jenkins M., Saunders M., Newbold P., Green R.H., Venge P., Lomas D.A., Barer M.R., Johnston S.L., Pavord I.D., Brightling C.E. Acute exacerbations of chronic obstructive pulmonary disease. Am. J. Respir. Crit. Care Med. 2011, 184:662-671.
35. Szafranski W., Cukier A., Ramirez A., Menga G., Sansores R., Nahabedian S., Peterson S., Olsson H. Efficacy and safety of budesonide/formoterol in the management of chronic obstructive pulmonary disease. Eur. Res. J. 2003, 21:74-81.
36. Nannini L., Cates C.J., Lasserson T.J., Poole P. Combined corticosteroid and long-acting beta-agonist in one inhaler versus placebo for chronic obstructive pulmonary disease. Cochrane. Database Syst. Rev. 2007, CD003794.
37. Ryrfeldt A., Andersson P., Edsbacker S., Tonnesson M., Davies D., Pauwels R. Pharmacokinetics and metabolism of budesonide: a selective glucocorticoid. Eur. J. Respir. Dis. 1982, (Suppl. 122):86-95.
38. Edsbacker S., Andersson P., Lindberg C., Paulson J., Ryrfeldt A., Thalen A. Liver metabolism of budesonide in rat, mouse, and man: comparative aspects. Drug. Metab. Dispos. 1987, 15:403-411.
39. Henry P.J., Rigby P.J., Goldie R.G. Distribution of beta 1- beta 2-adrenoceptors in mouse trachea and lung: a quantitative autoradiographic study. Br. J. Pharmacol. 1990, 99:136-144.
40. Hauck R.W., Bohm M., Gengenbach S., Sunder-Plassmann L., Fruhmann G., Erdmann E. Beta 2-adrenoceptors in human lung and peripheral mononuclear leukocytes of untreated and terbutaline-treated patients. Chest 1990, 98:376-381.